These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Amiodarone and thyroid]. Maby-Mottet V; Ollo D; Meyer P Rev Med Suisse; 2012 Nov; 8(362):2175-6, 2178-80. PubMed ID: 23240319 [TBL] [Abstract][Full Text] [Related]
3. [Thyroid dysfunction and amiodarone]. Lima J; Carvalho P; Molina MA; Rebelo M; Dias P; Vieira JD; Costa JM Arq Bras Endocrinol Metabol; 2013 Feb; 57(1):71-8. PubMed ID: 23440102 [TBL] [Abstract][Full Text] [Related]
4. Amiodarone and thyroid dysfunction. Padmanabhan H South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491 [TBL] [Abstract][Full Text] [Related]
16. Subclinical hypothyroidism, overt thyrotoxicosis and subclinical hypothyroidism: the subsequent phases of thyroid function in a patient chronically treated with amiodarone. Minelli R; Gardini E; Bianconi L; Salvi M; Roti E J Endocrinol Invest; 1992 Dec; 15(11):853-5. PubMed ID: 1291598 [TBL] [Abstract][Full Text] [Related]
17. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Baskin HJ; Cobin RH; Duick DS; Gharib H; Guttler RB; Kaplan MM; Segal RL; Endocr Pract; 2002; 8(6):457-69. PubMed ID: 15260011 [TBL] [Abstract][Full Text] [Related]
18. [Behavior of the cardiologist when faced with amiodarone-induced hormonal changes]. Gheri RG G Ital Cardiol; 1988 Nov; 18(11):945-7. PubMed ID: 2854798 [No Abstract] [Full Text] [Related]